NCT05241288View on ClinicalTrials.gov

Digihaler in Chronic Obstructive Pulmonary Disease (COPD)

NACompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

March 1, 2022

Primary Completion Date

February 13, 2023

Study Completion Date

February 13, 2023

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
COMBINATION_PRODUCT

Albuterol eMDPI DS

"Albuterol sulfate electronic multidose dry powder inhaler (Albuterol eMDPI) Digital System (DS) with 3 component devices:~Device 1: Albuterol eMDPI Device 2: Albuterol eMDPI Patient-facing smart device application (App) Device 3: Digital Health Platform (DHP, Cloud solution)"

Trial Locations (2)

27157

Wake Forest University Baptist Medical Center, Winston-Salem

27514

University of North Carolina at Chapel Hill, Chapel Hill

All Listed Sponsors
collaborator

Wake Forest University Health Sciences

OTHER

collaborator

Teva Branded Pharmaceutical Products R&D, Inc.

INDUSTRY

lead

University of North Carolina, Chapel Hill

OTHER